• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲胎蛋白水平与肿瘤总体积作为肝细胞癌切除术后复发预测指标的研究。一项回顾性队列研究。

Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.

作者信息

Zakaria Hazem M, Mohamed Anwar, Omar Hazem, Gaballa Nahla K

机构信息

Department of Hepatopancreatobiliary and Liver Transplant Surgery, National Liver Institute, Menoufia University, Egypt.

Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Egypt.

出版信息

Ann Med Surg (Lond). 2020 May 4;54:109-113. doi: 10.1016/j.amsu.2020.04.014. eCollection 2020 Jun.

DOI:10.1016/j.amsu.2020.04.014
PMID:32426129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7225379/
Abstract

BACKGROUND

Total tumor volume (TTV) and serum alfa fetoprotein (AFP) level are important risk factors linked with the high possibility of hepatocellular carcinoma (HCC) recurrence. The aim of the study was to evaluate the role of AFP/TTV ratio, as a prognostic marker, in the prediction of HCC recurrence after resection.

METHODS

Patients who underwent liver resection for HCC between 2010 and 2018 were retrospectively analyzed. Patients were divided into 2 groups; a group with AFP/TTV ≤2 and another group with AFP/TTV >2. Risk factors for HCC recurrence were recorded.

RESULTS

A total of 286 HCC patients underwent liver resection (184 patients with AFP/TTV ≤ 2, and 102 patients with AFP/TTV > 2). There was a significant difference between the 2 groups in the preoperative total bilirubin level, serum AFP level, mean tumor diameter, TTV, operative blood loss, microvascular invasion and hospital stay (all values < 0.05). The 1-, 3-, and 5-year tumor recurrence rates were 24.1%, 43%, and 57.6% respectively. The independent risk factors for tumor recurrence were AFP/TTV >2 (HR = 1.62, 95% CI = 1.29-1.98,  = 0.042), Macrovascular invasion (HR = 2.03, 95% CI = 2.17-2.38,  = 0.021, and microvascular invasion (HR = 1.36, 95% CI = 1.08-1.77,  = 0.019).

CONCLUSION

AFP/TTV ratio is a feasible prognostic marker for prediction of HCC recurrence after resection so, it can help in providing an intensive postoperative surveillance program to high risk patients for early detection and management of any recurrence.

摘要

背景

肿瘤总体积(TTV)和血清甲胎蛋白(AFP)水平是与肝细胞癌(HCC)高复发可能性相关的重要风险因素。本研究的目的是评估AFP/TTV比值作为一种预后标志物在预测肝癌切除术后复发中的作用。

方法

回顾性分析2010年至2018年间因肝癌接受肝切除术的患者。患者分为两组;AFP/TTV≤2组和AFP/TTV>2组。记录肝癌复发的风险因素。

结果

共有286例肝癌患者接受了肝切除术(184例AFP/TTV≤2,102例AFP/TTV>2)。两组在术前总胆红素水平、血清AFP水平、平均肿瘤直径、TTV、术中失血量、微血管侵犯和住院时间方面存在显著差异(所有值<0.05)。1年、3年和5年肿瘤复发率分别为24.1%、43%和57.6%。肿瘤复发的独立风险因素为AFP/TTV>2(HR=1.62,95%CI=1.29-1.98,P=0.042)、大血管侵犯(HR=2.03,95%CI=2.17-2.38,P=0.021)和微血管侵犯(HR=1.36,95%CI=1.08-1.77,P=0.019)。

结论

AFP/TTV比值是预测肝癌切除术后复发的可行预后标志物,因此,它有助于为高危患者提供强化术后监测方案,以便早期发现和处理任何复发情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f4e/7225379/4d0f45f903d5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f4e/7225379/4d0f45f903d5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f4e/7225379/4d0f45f903d5/gr1.jpg

相似文献

1
Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.甲胎蛋白水平与肿瘤总体积作为肝细胞癌切除术后复发预测指标的研究。一项回顾性队列研究。
Ann Med Surg (Lond). 2020 May 4;54:109-113. doi: 10.1016/j.amsu.2020.04.014. eCollection 2020 Jun.
2
The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.术前甲胎蛋白水平与肿瘤总体积比值作为肝移植后肝细胞癌的预后因素。
Medicine (Baltimore). 2021 Jul 2;100(26):e26487. doi: 10.1097/MD.0000000000026487.
3
α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.甲胎蛋白与肿瘤总体积比值预测肝癌术后肿瘤复发。
J Gastrointest Surg. 2013 Apr;17(4):730-8. doi: 10.1007/s11605-012-2081-5. Epub 2012 Nov 28.
4
Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer.评估总肿瘤体积和移植前甲胎蛋白水平作为肝细胞癌患者肝移植选择标准的情况。
Transplant Proc. 2013 Jun;45(5):1899-903. doi: 10.1016/j.transproceed.2012.12.010.
5
Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.肝细胞癌患者肝切除术后总肿瘤体积作为生存预后价值的回顾性队列研究。
Ann Med Surg (Lond). 2020 Apr 7;54:47-53. doi: 10.1016/j.amsu.2020.04.001. eCollection 2020 Jun.
6
A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.基于总肿瘤体积的肝细胞癌新预后模型:台北综合评分系统。
J Hepatol. 2010 Jul;53(1):108-17. doi: 10.1016/j.jhep.2010.01.038. Epub 2010 Mar 31.
7
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
8
Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.同型半胱氨酸:甲胎蛋白阴性肝细胞癌肝移植的新型预后生物标志物。
Cancer Biomark. 2020;29(2):197-206. doi: 10.3233/CBM-201545.
9
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.术前血清甲胎蛋白(AFP)水平与肝癌(HCC)肝切除术后预后的相关性分析。
World J Surg Oncol. 2013 Aug 27;11:212. doi: 10.1186/1477-7819-11-212.
10
Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.肿瘤总体积是米兰标准定义的肝细胞癌肿瘤负荷的更好标志物。
World J Surg. 2013 Jun;37(6):1348-55. doi: 10.1007/s00268-013-1978-9.

引用本文的文献

1
A Systematic Review and Meta-Analysis of Oncologic Liver Resections in Low- and Middle-Income Countries: Opportunities to Improve Evidence and Outcomes.低收入和中等收入国家肿瘤性肝切除术的系统评价与荟萃分析:改善证据和结果的机会
J Surg Oncol. 2025 Apr;131(5):865-878. doi: 10.1002/jso.27928. Epub 2024 Nov 21.
2
A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection.一种新的基于炎症指标和肿瘤负荷评分(TBS)的模型,用于预测肝癌(HCC)肝切除术后的复发。
Sci Rep. 2022 May 23;12(1):8670. doi: 10.1038/s41598-022-12518-5.
3
Ratio of CA19-9 Level to Total Tumor Volume as a Prognostic Predictor of Pancreatic Carcinoma After Curative Resection.

本文引用的文献

1
[Surgical treatment of hepatic tumors-liver resection and transplantation].[肝脏肿瘤的外科治疗——肝切除与肝移植]
Internist (Berl). 2020 Feb;61(2):147-157. doi: 10.1007/s00108-020-00754-8.
2
STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery.STROCSS 2019 指南:加强外科学队列研究报告。
Int J Surg. 2019 Dec;72:156-165. doi: 10.1016/j.ijsu.2019.11.002. Epub 2019 Nov 6.
3
Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study.
CA19-9 水平与肿瘤总体积比值作为可切除胰腺癌患者预后预测指标的研究
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221078438. doi: 10.1177/15330338221078438.
4
MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer.微小RNA-374b-5p抑制KDM5B诱导的胰腺癌上皮-间质转化。
Am J Cancer Res. 2021 Aug 15;11(8):3907-3920. eCollection 2021.
5
The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.年龄、国际标准化比值、白蛋白和γ-谷氨酰转肽酶(AIAG)、肿瘤大小及甲胎蛋白(AFP)分期联合作为乙型肝炎相关肝细胞癌的预后模型
Int J Gen Med. 2021 Aug 10;14:4291-4301. doi: 10.2147/IJGM.S323293. eCollection 2021.
定义和预测肝癌肝切除术后早期复发:多机构研究。
HPB (Oxford). 2020 May;22(5):677-689. doi: 10.1016/j.hpb.2019.09.006. Epub 2019 Oct 10.
4
Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong.接受根治性肝切除术患者术前甲胎蛋白(AFP)水平的预后价值——对香港1182例患者的分析
Transl Gastroenterol Hepatol. 2019 Jul 11;4:52. doi: 10.21037/tgh.2019.06.07. eCollection 2019.
5
Prognostic Factors for Post-recurrent Survival in Hepatocellular Carcinoma After Curative Resection.肝细胞癌根治性切除术后复发后生存的预后因素
Anticancer Res. 2019 Jun;39(6):3033-3038. doi: 10.21873/anticanres.13436.
6
Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.复发性肝细胞癌的外科治疗:实现长期生存。
Ann Surg. 2021 Apr 1;273(4):792-799. doi: 10.1097/SLA.0000000000003358.
7
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.中国多中心研究:肝癌切除术后晚期复发的危险因素、模式和结局。
JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334.
8
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.血清甲胎蛋白总肿瘤体积比作为肝癌切除术后复发的预测指标。
Surgery. 2018 May;163(5):1002-1007. doi: 10.1016/j.surg.2017.10.063. Epub 2017 Dec 25.
9
Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌活体肝移植预后的预测因素
Indian J Surg. 2017 Aug;79(4):299-307. doi: 10.1007/s12262-016-1474-1. Epub 2016 Apr 7.
10
Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.肿瘤总体积可预测肝细胞癌患者肝切除术后的生存率。
Tumour Biol. 2016 Jul;37(7):9301-10. doi: 10.1007/s13277-016-4794-7. Epub 2016 Jan 15.